Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Poly (ADP-ribose) polymerase

A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix: An NRG Oncology/Gynecologic Oncology Group Study
Charles Kunos, Wei Deng, Dawn Dawson, Jayanthi S. Lea, Kristine M. Zanotti, Heidi J. Gray, David P. Bender, Perry P. Guaglianone, Jori S. Carter, Kathleen N. Moore

International Journal of Gynecologic Cancer Mar 2015, 25 (3) 484-492; DOI: 10.1097/IGC.0000000000000380